Medicine and Dentistry
Hemostat
100%
Liver Cirrhosis
97%
Thrombin
94%
Liver Transplantation
76%
Von Willebrand Factor
54%
Machine Perfusion
54%
Von Willebrand Factor Cleaving Proteinase
44%
Liver Disease
42%
Platelet
41%
In Vitro
39%
Acute on Chronic Liver Failure
38%
Blood Stasis
35%
Antithrombotic
33%
Fibrinolysis
30%
Partial Hepatectomy
28%
Fibrinogen
28%
Thrombocyte Activation
25%
Thrombomodulin
23%
Ex Vivo
23%
Acute Liver Failure
22%
Procoagulant
21%
Bleeding
21%
Liver Injury
21%
Recombinant Blood Clotting Factor 7a
20%
Fibrin Clot
19%
Decompensated Liver Cirrhosis
18%
Euglobulin Lysis Test
16%
Thromboplastin
15%
Fresh Frozen Plasma
15%
Hypercoagulability
15%
Blood Clotting Factor
14%
Heparin
14%
Anticoagulation
14%
Thrombosis
14%
COVID-19
13%
Hepatitis B
13%
Prospective Cohort Study
13%
Hepatocellular Carcinoma
13%
End Stage Liver Disease
13%
Prothrombin
13%
Fibrinogen Concentrate
12%
Neutrophil
10%
Blood Clotting
10%
Microthrombus
10%
Factor XIII
10%
Chronic Liver Disease
9%
Prothrombin Complex
9%
Volunteer
9%
Disease Severity
9%
Nonalcoholic Fatty Liver
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
74%
Thrombin
69%
Anticoagulant Agent
56%
Von Willebrand Factor
47%
Hemostatic Agent
38%
Acute on Chronic Liver Failure
36%
Von Willebrand Factor Cleaving Proteinase
30%
Blood Stasis
25%
Bleeding
24%
Decompensated Liver Cirrhosis
20%
Liver Disease
20%
Mouse
19%
Fibrinolytic Agent
18%
End Stage Liver Disease
18%
Blood Clotting Factor 13
16%
Prothrombin
16%
Thrombomodulin
16%
Acute Liver Failure
15%
Procoagulant
14%
Hypercoagulability
14%
D Dimer
14%
Liver Cell Carcinoma
13%
Blood Clotting Factor
13%
Hepatitis B
13%
Liver Injury
13%
Antithrombin
12%
Recombinant Blood Clotting Factor 7a
12%
Reperfusion Injury
12%
Heparin
12%
Inflammation
10%
Thrombin Activatable Fibrinolysis Inhibitor
10%
Fibrinogen
9%
Disease Severity
9%
Normal Human
9%
Disease
9%
Low Molecular Weight Heparin
9%
Proteinase
8%
Thrombosis
8%
Prothrombin Complex
7%
Liver Failure
7%
Hepatitis C
7%
Cross-Sectional Study
7%
Von Willebrand Disease
7%
Thromboplastin
7%
Liver Dysfunction
6%
Anticoagulant Activity
6%
Angiogenic Protein
6%
Clinical Trial
6%
Brain Death
6%
Stability of Liquid
6%
Keyphrases
Cirrhosis
34%
Von Willebrand Factor
34%
Thrombin Generation
23%
Acute Liver Failure
20%
Liver Transplantation
20%
Transplantation
16%
ADAMTS13
16%
Hemostasis
15%
Anticoagulants
14%
Plasma Parameters
13%
Prospective Cohort Study
13%
Acutely Ill Patients
13%
Acute-on-chronic Liver Failure
13%
End-stage Liver Disease
11%
Liver
10%
Hypercoagulability
10%
Hemostatic System
10%
Fibrinolytic Proteins
10%
Clot Lysis
9%
Platelets
9%
Donor Liver
9%
Pediatric Liver Transplantation
9%
Healthy Controls
9%
In Vivo Efficacy
9%
Haemostatic Proteins
9%
Liver Disease
8%
Poor Outcome
8%
Human Donor
8%
Patients with Liver Disease
8%
Antihemostatic
8%
Factor Level
8%
Fibrinolysis
7%
Prodrug
7%
Coagulation
7%
Partial Hepatectomy
7%
Anticoagulant Drugs
7%
Von Willebrand Disease
7%
Neutrophil Extracellular Traps
7%
Hepatocellular Carcinoma
6%
CCR5Δ32
6%
Pancreatic Fluid
6%
Thrombolytic Potential
6%
Etiology
6%
Multicenter Cross-sectional Study
6%
Clinical Outcomes
6%
Platelet Transfusion
6%
Bleeding
6%
Thrombodynamics
6%
Portal Vein
6%
Hepatitis B&C
6%
